New drug aims to blunt meth's high in users not ready to quit
NCT ID NCT06721494
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 16 times
Summary
This study tests a new medicine called CS-1103 in 40 healthy adults who use methamphetamine but are not looking for treatment. Participants get a single dose of methamphetamine along with CS-1103 to see if the drug can safely reduce meth's effects and help the body get rid of it faster. The goal is to find a way to manage methamphetamine intoxication and support future treatment options.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE ABUSE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
California Clinical Trials Medical Group
RECRUITINGGlendale, California, 91206, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.